Table 1 Characteristics of the included studies
Author | Year | Population | Region | Design | Study setting | Data collection | Treatment | Funding | Quality |
|---|---|---|---|---|---|---|---|---|---|
Abdissa D. & Hirpa [35] | 2022 | DM | Oromia | Cross-sectional | Primary, general, and referral hospitals | IAS | Oral agents and insulin | NR | 7.5 |
Bekele S. et al. [31] | 2017 | DM | SNNPR | Cross-sectional | General hospital | IAS | Not explained | NR | 8 |
Haile K. & Timerga A. [36] | 2020 | T2DM | Oromia | Cross-sectional | Tertiary hospital | IAS | Not explained | JU | 9 |
Kebede W. M. et al. [26] | 2021 | T2DM | Amhara | Cross-sectional | Tertiary hospital | IAS | Not explained | Nil | 8.5 |
Woyesa S. et al. [37] | 2021 | DM | Oromia | Cross-sectional | Tertiary hospital | IAS | Insulin and oral agents | JU | 7 |
Wuhib M. et al. [28] | 2021 | DM | Amhara | Cross-sectional | Tertiary hospital | IAS and lab test | Not explained | NR | 9 |
Fikremariam T. & Reddy P. P. [29] | 2020 | DM | Amhara | Cross-sectional | Tertiary hospital | IAS and lab test | Not explained | BDR | 7.5 |
Biadgo B. et al. [27] | 2018 | T2DM | Amhara | Cross-sectional | Tertiary hospital | IAS and lab test | Not explained | Nil | 8.5 |
Birarra M. K. & Gelaye D. A. [30] | 2018 | T2DM | Amhara | Cross-sectional | Tertiary hospital | IAS and lab test | Not explained | NR | 8 |
Woyesa S. B. et al. [32] | 2017 | T2DM | SNNP | Cross-sectional | Tertiary hospital | IAS and lab test | Not explained | JU | 8.5 |
Gebremeskel G. G. et al. [38] | 2019 | T2DM | Tigray | Cross-sectional | Tertiary hospital | IAS and record review | Insulin and oral agents | Nil | 7 |
Abebe G. et al. [33] | 2022 | T2DM | SNNPR | Case control | General hospital | IAS and record review | Not explained | AMU | 9 |
Wube B. T. et al. [34] | 2020 | T2DM | SNNPR | Cross-sectional | Tertiary hospital | IAS | Not explained | NR | 8.5 |
Birle M. et al. [39] | 2019 | T2DM | AA | Cross-sectional | Tertiary hospital | IAS and lab test | Not explained | AMU | 7.5 |